ESMO Congress 2026

Welcome to the Elsevier exhibit landing page for ESMO 2026!

On this page, you’ll find information about our journals, our freely accessible article collection, the Elsevier Oncology Journal Network, and the ESMO journal portfolio.

23–27 October 2026 | IFEMA Madrid

Visit the Elsevier at Booth #P8091opens in new tab/window

Article collection

Annals of Oncology

• Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER)opens in new tab/window

• GLP-1 receptor agonist use and cancer risk in obese nondiabetic adultsopens in new tab/window

• Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate canceropens in new tab/window

ESMO Gastrointestinal Oncology

• Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE studyopens in new tab/window

• DESTINY-Gastric05 phase III trial of first-line trastuzumab deruxtecan, chemotherapy, and pembrolizumab in HER2-positive gastric or gastroesophageal junction canceropens in new tab/window

• Systematic review and meta-analysis of studies assessing circulating tumor DNA kinetics in metastatic colorectal canceropens in new tab/window

Immuno-Oncology and Technology

• Redirecting engineered immune cells using G protein-coupled receptors in cancer therapyopens in new tab/window

• Safety and efficacy of immune checkpoint inhibitors in patients with melanoma and pre-existing autoimmune conditions: a systematic review and meta-analysisopens in new tab/window

• Refractory microsatellite-stable metastatic colorectal cancer: a comparison between botensilimab + balstilimab and current standard of careopens in new tab/window

ESMO Open

• Hope and despair in cancer and other illnesses: a clinical framework for adaptive hope across the illness trajectoryopens in new tab/window

• More than survival curves: why every oncologist has to read this article on adaptive hopeopens in new tab/window

• Timing of breast cancer diagnosis postpartum and survival in women with germline pathogenic variantsopens in new tab/window

ESMO Rare Cancers

• The value of MMR characterization and efficacy of checkpoint inhibitor in patients with small-bowel adenocarcinomas: a retrospective real-world cohort studyopens in new tab/window

• Stage shift from Masaoka-Koga to ninth TNM system in thymic epithelial tumorsopens in new tab/window

• Mirdametinib approval for neurofibromatosis type 1 with inoperable plexiform neurofibromas: the journey of MEK inhibitorsopens in new tab/window

ESMO Real World Data & Digital Oncology

• Mapping population-based cancer registries in Europe: coverage, data availability, and capacity for real-world data generationopens in new tab/window

• Feasibility of a prospective real-time monitoring system capturing real-world data from elderly patients with acute myeloid leukemiaopens in new tab/window

• Leveraging artificial intelligence to strengthen cancer care in Belgium: a policy brief from the Belgian Europe’s Beating Cancer Plan Mirror Groupopens in new tab/window

Elsevier’s Oncology Journal Network